Disflatyl

Quick links to important sections

Disflatyl

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Disflatyl

Quick Facts

Property Description
Active ingredient Simethicone (Activated Dimethicone)
Form Oral preparations (e.g., chewable tablets, suspension, drops)
Pharmacological class Gastrointestinal Agent (Antiflatulent)
Common use Relief of symptoms associated with excess intestinal gas
Origin Synthetic silicone polymer

What Type of Medicine is Disflatyl (Simethicone)?

Disflatyl is a Gastrointestinal agent specifically classified as an antiflatulent medication. Its single active ingredient is Simethicone, a highly stable, synthetic silicone polymer that functions as a surface-active agent. Simethicone is used for the management and treatment of flatulence and bloating, a function supported by pharmacological studies.

Simethicone is defined as an activated poly(dimethylsiloxane), an inert substance that is virtually non-absorbed by the body. This means its entire therapeutic action takes place locally within the gut lumen, which contributes to its distinction as a physical agent rather than a systemic pharmacological drug.


What is the Composition and Form of Disflatyl?

Disflatyl is a single-component product administered orally, available in various pharmaceutical preparations to suit different needs. These common dosage forms include chewable tablets, oral drops, and suspension formulations. The brand's focus on oral drops and suspension forms specifically positions it for use across different patient groups, including infants and young children, where a liquid formulation is often preferred for ease of administration.

Its composition relies on the active Simethicone combined with standard pharmaceutical bases or excipients. This range of forms ensures flexible administration of the antiflatulent agent for managing episodic gastrointestinal discomfort.


What is the General Purpose of Disflatyl?

The general purpose of Disflatyl is to provide rapid, localized relief from the pressure and discomfort caused by intestinal gas and flatulence. It achieves this by physically modifying the gas bubbles trapped in the digestive system.

The core mechanism principle involves the reduction of surface tension of the small, foamy gas bubbles within the gut's mucus lining. This action causes the tiny bubbles to undergo coalescence, bringing together the small gas bubbles in the gut to form bigger bubbles. These larger gas pockets are significantly easier for the body to pass or expel, allowing trapped air to pass through more easily.

Regulatory References

  1. Simethicone: MedlinePlus Drug Information
  2. Simethicone - StatPearls - NCBI Bookshelf

What side effects are possible with Disflatyl?

Possible Side Effects and Safety Information

The safety profile for Disflatyl (Simethicone) is shaped by its physical mechanism of action: it is an inert agent that is virtually non-absorbed by the body, minimizing the potential for systemic toxicity. All safety information is based strictly on documentation from government regulatory authorities.


Official Adverse Reactions and Classifications

The frequency of most reported adverse events is classified as Not known, as estimation is difficult from post-marketing reports. The possible side effects documented in official labeling primarily fall under two categories:

  • Gastro-Intestinal Disorders: Reported effects include gastrointestinal discomfort such as nausea, vomiting, constipation, or loose stools.
  • Immune System Disorders: Rare but clinically significant reactions are linked to hypersensitivity.

Serious Safety Considerations

The most important adverse reactions defined in regulatory documents are manifestations of hypersensitivity. These may include severe effects such as face oedema (swelling) or dyspnoea (difficulty breathing).


Population-Specific Notes and Restrictions

Safety Domain Regulatory Statement
Pregnancy and Lactation No effects are anticipated on the fetus or breastfed infant due to negligible systemic exposure.
Contraindication The medicine is contraindicated in individuals with known hypersensitivity to the active ingredient or any excipients.
Test Interference Official sources note the potential for Simethicone to cause a false-negative result in the gastric guaiac test.

This regulatory profile confirms that safety concerns are focused on pre-existing sensitivities and localized effects, rather than dose- or duration-related systemic risk.

Overdose and Emergency Response

Overdose Profile and Toxic Manifestations

Disflatyl (Simethicone) is classified by regulatory agencies as a surface-active, antiflatulent agent. The active ingredient is a synthetic silicone polymer that is not absorbed systemically from the gastrointestinal tract. This pharmacological characteristic fundamentally defines the official regulatory perspective on overdose.

Due to the substance's inert nature and virtual lack of systemic absorption, government-authorized prescribing information confirms that toxic systemic effects do not occur following overdose. As a result, specific life-threatening complications, such as cardiovascular or neurological events, are not officially documented as manifestations of Simethicone chemical toxicity. Manifestations of ingesting excessive quantities are generally limited to non-specific gastrointestinal discomfort resulting from the presence of the non-absorbed material within the digestive system.

Required Emergency Actions

Regulatory guidance on managing any suspected overdose event is precise and focuses on mandated procedural actions. Official labeling mandates the immediate requirement to seek emergency medical attention or to contact a Poison Control Center immediately.

Management and Antidote Information

The established management protocol is based on symptomatic and supportive treatment. Official documentation explicitly states that no specific antidote is known for Simethicone overdose. Therefore, medical care primarily centers on supportive observation and general clinical treatment. No population-specific overdose considerations for pediatric or elderly patients are separately documented in official labeling.

Therapeutic Uses of Disflatyl

What Disflatyl Treats: Main Uses and Benefits

Disflatyl is commonly used to provide symptomatic support across therapeutic domains marked by digestive discomfort and pressure. It offers targeted relief for challenges where excess intestinal gas creates noticeable physiological strain. The medication is applied in therapeutic contexts where supportive symptom management is appropriate, particularly for flatulence, bloating, pressure, and fullness due to excess gas.


Therapeutic Domains and Symptom Clusters

The medication is used in conditions where symptoms of heightened physiological activity occur, such as the bloating in Irritable Bowel Syndrome (IBS) and Functional Dyspepsia, or gas pains following surgical procedures. It assists with managing symptom clusters related to abdominal distension and gas cramps, helping patients cope more steadily with difficult episodic discomfort.

It is relevant in conditions characterized by periods of heightened symptoms, such as acute or recurrent episodes of gas and fullness, and is also applicable for managing the physical symptoms associated with excessive air swallowing (aerophagia) in diverse patient groups. The support provided focuses on easing the symptoms related to physical discomfort caused by excess gas.

Quick Fact Relief for Gas-Related Distress
Main Target Abdominal Pressure, Bloating, Cramping
Primary Use Context Symptomatic relief in acute or episodic states
Core Benefit Supports improved comfort and helps maintain functional stability

Eligibility and Restrictions for Use

Who Can and Cannot Use Disflatyl?

Disflatyl (Simethicone) eligibility is largely defined by its non-systemic action within the digestive tract, resulting in minimal restrictions across patient populations. Official regulatory documents establish its use from infancy through older adulthood, with specific dosing protocols available for all age groups.


Absolute Non-Eligibility and Key Restrictions

The medicine is contraindicated for any patient with a known hypersensitivity or allergy to the active ingredient, simethicone, or to any other component of the formulation. Patients with suspected or confirmed gastrointestinal obstruction or intestinal perforation are typically advised against its use.

Population Group Regulatory Status
Pregnancy and Lactation Use is acceptable and generally safe; the drug is not absorbed into the bloodstream.
Renal/Hepatic Impairment No dose adjustment or restriction is required, consistent with its non-systemic nature.
Phenylketonuria (PKU) Use may be restricted if the specific dosage form contains phenylalanine as an excipient.

Eligibility exclusions primarily concern allergic history and physical limitations of the digestive system, rather than systemic health issues.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Disflatyl

Interaction Scope

Category Official Regulatory Information
Interacting Medicines Levothyroxine (and related thyroid hormones).
Mechanistic Basis Local physical interaction resulting in reduced oral bioavailability of the co-administered drug. Simethicone is not absorbed systemically, precluding metabolic/systemic interactions.
Timing Rule Co-administration with Levothyroxine must be separated by at least 4 hours to avoid decreased systemic exposure.
Other Restrictions Restriction applies to Levothyroxine unless the four-hour interval is implemented. No official restrictions exist for food, drinks, or alcohol.

Interaction Classifications (High-Level)

Classification Official Regulatory Information
Severity / Constraint Classified as an interaction requiring a mandatory administration interval to mitigate risk.
Regulatory Basis Information is documented in official drug labels and regulatory guidance, such as that issued by the FDA.

Resulting Interaction Structure

Official interaction statements:

  • Simethicone is non-systemically absorbed, resulting in no expected systemic pharmacokinetic or pharmacodynamic interactions.
  • Co-administration with Levothyroxine may reduce the thyroid hormone's systemic exposure due to physical binding.
  • A temporal separation of at least four hours is required when administering Simethicone with Levothyroxine.

Connection to the overall interaction profile: The product's regulatory interaction profile is defined by the absence of systemic effects, a fact confirmed by its non-absorbed nature. The only documented constraint is a mandatory time separation required when combining the drug with Levothyroxine, establishing the single, clinically relevant interaction pattern.

Mechanism of Action

Disflatyl (Simethicone) operates exclusively through a non-systemic, physical mechanism localized within the gastrointestinal (GI) lumen contents. The molecule is chemically inert and remains unabsorbed, ensuring it engages no biological receptors, enzymes, or systemic signaling pathways.

Its action focuses on the gas-liquid interface of gas bubbles and foam within the gut's mucus lining. Simethicone functions as a surfactant that drastically reduces the surface tension of these bubbles, initiating the mechanical process of foam destabilization. This physical interaction triggers coalescence, whereby numerous small, unstable bubbles merge together to form larger pockets of free gas .

This transformation from a dispersed foam state to a consolidated, free gas state facilitates the body's natural physiological processes of gas clearance, contributing to gas expulsion through eructation or flatus. This mechanistic restructuring of the foam directly results in a decrease in intraluminal volume and pressure exerted on the bowel wall.

Dosage and Administration Information

The administration of Disflatyl (simethicone) involves specific protocols regarding the route, dosing, frequency, and preparation of the medicine. This antiflatulent agent is for oral administration in all available forms, including chewable tablets, capsules, and liquid drops.

Dosing and Frequency

Disflatyl is used on an as-needed (PRN) basis for symptomatic use, taken up to four times daily. The proper timing for administration is after meals and at bedtime.

Population Single Dose Range Maximum Recommended Daily Dose
Adults (Self-Medication) 40 mg to 180 mg 500 mg in 24 hours
Pediatric (Under 2 years) 20 mg (liquid drop formulations) 240 mg in 24 hours

Administration Requirements

Specific instructions apply to each dosage form to ensure proper use:

  • Chewable Tablets must be chewed thoroughly before swallowing; they should not be swallowed whole.
  • Liquid Suspensions/Drops must be shaken well before each use. The correct dose must be measured precisely using the calibrated dropper or dosing device provided with the product.

For general use, the medication is intended for short-term courses (e.g., typically not exceeding 14 days for self-medication) unless otherwise directed by a healthcare provider.

No specific dose adjustments are required for older adults, as the drug is not absorbed systemically.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Disflatyl (Simethicone)

Research Evidence for Simple Bloating and Intestinal Gas

Research has examined Simethicone's use for common, episodic symptoms of general gas, bloating, and abdominal discomfort. This area of study primarily involves short-term Randomized Controlled Trials (RCTs) and older double-blind, placebo-controlled trials. These trials were evaluated in general adult populations experiencing functional digestive discomfort. The studies often monitored patient-reported outcomes describing perceived discomfort and symptoms like fullness and abdominal pressure, typically over defined time intervals lasting a few weeks.

Studies report patterns related to measured outcomes of physical discomfort, which were compared to observations in groups receiving placebo. The evidence base, including clinical trials and regulatory data, is consistent with the product's classification as an Antiflatulent agent. However, the follow-up durations were limited in many of these foundational trials. There is limited information for long-term outcomes regarding the repeated or extended use of Simethicone for these acute symptoms.

Studies on Functional Digestive Disorders: IBS and Dyspepsia

Simethicone was studied for its use in chronic functional digestive disorders, such as Functional Dyspepsia (FD) and Irritable Bowel Syndrome (IBS). The research often involves systematic reviews and RCTs where Simethicone was evaluated in combination with other therapeutic agents. The research examined outcomes related to systemic or functional imbalance, including overall symptom relief and the severity of specific issues like abdominal distension. The evidence is characterized by mixed findings. While some studies report observations related to changes in bloating measures, the results for Simethicone monotherapy (used alone) for core IBS symptoms appear to be less consistent. Comparative evidence is lacking for Simethicone as a stand-alone agent versus other single-agent treatments.

Evidence as a Procedural Aid for Diagnostic Imaging

Research regarding Simethicone's use as a defoaming agent to aid visualization during medical procedures is highly consistent. RCTs and meta-analyses explored objective outcomes, such as the quality of mucosal visualization scores and the number of air bubbles present. These studies consistently show patterns related to measured changes in the presence of foam and bubbles, consistent with the physical properties of the silicone polymer. The agent is utilized in many standard protocols used for diagnostic imaging preparation.

Research Landscape for Use in Infantile Colic

Simethicone was studied for its use in infants experiencing colic. Multiple high-quality systematic reviews reported that there is limited information to support a consistent change in the primary outcome of crying time compared to control groups. Consequently, certainty remains low in this specific application.

Key Studies & References Simethicone (StatPearls, NIH) - Summary of evidence and regulatory status

Frequently Asked Questions (FAQ)

Common questions about Disflatyl (FAQ)

Q: What should I do if I forget to take Disflatyl?

Official patient information often addresses what to do if a regular dose is missed. Generally, if the medicine is taken on a periodic basis, a missed dose is administered as soon as it is remembered. Regulatory guidance indicates that if the time for the next scheduled dose is near, the missed dose is typically skipped, and the individual follows the normal schedule without administering two doses at once.

Q: Can Disflatyl be used by people who have diabetes?

Official patient guidance indicates that a person on a low-sugar or other special diet is typically instructed to check the product label. This is because most medicines contain excipients (inactive ingredients), and the regulatory position is that confirming the specific product's sugar or carbohydrate content with a healthcare professional is necessary, as excipients can vary by formulation.

Q: Why does the packaging for Disflatyl say it’s not for infants?

Official labeling for certain product forms or jurisdictions may state that the active ingredient should not be used in children under two years of age except when done under the supervision of a healthcare provider. While specific pediatric dosing is available for infants, official regulatory use is defined by the need for professional supervision for the administration of medicine to this very young age group.

Q: Can I take Disflatyl along with an antacid?

Simethicone is frequently combined with antacid ingredients in many over-the-counter multi-ingredient preparations. Regulatory standards confirm that the use of this medicine with other antacid ingredient(s) is permitted, as long as the labeling requirements for both products are properly followed.

Q: Does Disflatyl have any effect on mental clarity or mood?

Official product information sometimes reports that uncommon side effects can include somnolence, which is a state of drowsiness. Rare effects related to the central nervous system, such as coordination abnormality, are also noted in some regulatory documentation.

Q: Is Disflatyl available without a prescription in some countries?

The active ingredient, Simethicone, is widely classified by regulatory bodies as an over-the-counter (OTC) medication in many countries around the world. It is generally available without a prescription for the symptomatic relief of gas and bloating.

Q: Is it true that Disflatyl is generally considered safe?

The medicine is described in official regulatory sources as having a safety profile considered favorable due to its non-systemic mechanism of action. Because the drug is not absorbed orally, it is described in official documentation as apparently nontoxic, and the risk of systemic side effects is considered minimal.

Q: Why do some people say Disflatyl helps with bloating and gas?

The product is classified as an antiflatulent because its action is purely physical and mechanical. It acts as a surfactant that lowers the surface tension of gas bubbles in the gut. This causes the small, trapped bubbles to join together, forming larger gas pockets that are physiologically better positioned for the body's natural clearance processes.

Q: Are there any specific foods or drinks that should be avoided when taking Disflatyl?

Official interaction maps and regulatory guidance indicate that no specific restrictions exist for food, drinks, or alcohol that prohibit the use of the medicine. Official patient information notes that general use may be discussed with a healthcare professional, especially when regularly consuming food, alcohol, or tobacco.

Q: Can Disflatyl affect the absorption of vitamins or supplements?

While there is a documented physical interaction that can reduce the absorption of levothyroxine, a thyroid hormone, official sources offer limited information regarding its effects on general vitamins or supplements. For this reason, official patient guidance often advises a time separation between taking this medicine and other substances.

Q: How is Disflatyl different from a probiotic supplement?

Disflatyl is a physical agent classified as an antiflatulent, and its function is entirely mechanical on existing gas bubbles. In contrast, a probiotic is a biological agent intended to introduce living microorganisms to the gut. These two classes of substances work in fundamentally different ways.

Q: Does Disflatyl have a drug warning about driving or operating machinery?

As some individuals may experience dizziness or somnolence (drowsiness) as a reported side effect, this may be relevant to the safe operation of machinery or driving. Product information generally includes a statement describing the need for individuals to note how they respond to the medicine before engaging in such activities.

Q: Is Disflatyl known to cause dry mouth or increased thirst?

Official product information lists dry mouth as an uncommon gastrointestinal adverse event. Increased thirst, however, is not explicitly reported as a possible side effect in the primary regulatory documentation.

Q: Are there different strengths or forms (e.g., tablet vs. capsule) of Disflatyl?

Regulatory records show the product is manufactured in a variety of pharmaceutical preparations to suit different patient needs. These forms include capsules, liquid-filled capsules, chewable tablets, tablets, and oral suspensions. Multiple strengths are available, ranging from lower doses up to 180 mg and beyond.

Q: Has Disflatyl been recalled recently due to safety concerns?

Regulatory bodies, such as the FDA, have issued voluntary recalls for combination products that contain the active ingredient mixed with other agents. These recalls were typically due to issues like microbial contamination in specific batches and related to the formulation, not the active Simethicone ingredient itself.

Q: Can Disflatyl interact with herbal remedies or supplements?

Official sources provide limited specific information regarding interactions with complementary medicines, herbal remedies, or supplements. This is because these substances are not routinely tested against pharmaceutical products in the same way, and official patient guidance often advises a time separation.

Q: Is Disflatyl safe to take if I also take a blood pressure medication?

Simethicone is virtually non-absorbed by the body and is inert, meaning it is not expected to cause any systemic pharmacokinetic or pharmacodynamic interactions. For this reason, there are no expected direct interactions with blood pressure medications.

Q: Does Disflatyl have any known effects on liver function?

The active ingredient, Simethicone, does not undergo hepatic (liver) metabolism and is not absorbed systemically. Official safety criteria specify that no dose adjustment is required for individuals with impaired liver function.

Q: Is it possible to become dependent on Disflatyl with regular use?

The active ingredient is not classified as a controlled medication by regulatory bodies. Its non-systemic, physical mechanism of action, which involves no biological receptors, supports a profile inconsistent with the development of substance dependence.

Q: What happens if I accidentally take too much Disflatyl?

Due to the drug’s non-absorbed nature, the risk of toxicity from oral overdose is considered minimal. Official guidance states that there is no specific treatment for an overdose, and the course of action is generally limited to discontinuing the medicine.

Q: Is there a generic version of Disflatyl available?

The active ingredient, Simethicone, is available as a generic medication in many jurisdictions. This classification often results in lower-cost options compared to some branded products.

Q: Does Disflatyl come with a patient information leaflet, and what should it include?

As a regulated product, the medicine typically comes with a patient information leaflet (PIL) or similar document. This leaflet is required to contain key information, including how to take the medicine, how to handle a missed dose, and a complete list of warnings and possible side effects.

Q: Is Disflatyl a substance that can be tested for in drug screening?

Due to its non-systemic nature, the active ingredient is not absorbed into the bloodstream and is not metabolized by the body. Therefore, the ingredient is not a substance that is typically included in standard drug screening panels for substances of abuse.

Q: Do studies suggest Disflatyl is more effective for some symptoms than others?

Studies and regulatory reviews show that the research evidence is more consistent and robust regarding its use as a defoaming agent to aid visualization during medical procedures. Conversely, research has been more mixed and less consistent regarding primary outcomes when the medicine is studied for certain symptomatic issues like infantile colic.

How should Disflatyl be stored and disposed of?

The official storage and disposal requirements for Disflatyl (Simethicone) are based on regulatory labeling to maintain the product's quality and integrity.

  • Storage Temperature: The medicine must be stored at room temperature. Some liquid formulations may specifically require storage below 30 C.
  • Protection: The product must be kept away from excess heat and moisture (e.g., not in the bathroom) and protected from light.
  • Container Rules: Keep the medicine in its original container, and ensure the container is tightly closed.
  • Child Safety: All product forms must be stored out of the sight and reach of children, and safety caps must be locked.
  • Disposal: Unused or expired medication should be discarded in accordance with local regulations. The preferred method is a drug take-back program. If not available, the product should be mixed with an undesirable substance (like coffee grounds or kitty litter) and sealed before disposal in household trash; do not flush unless specifically instructed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Disflatyl found in:

A-Z Index: